Growth Metrics

Tvardi Therapeutics (TVRD) Return on Assets: 2014-2017

Historic Return on Assets for Tvardi Therapeutics (TVRD) over the last 4 years, with Sep 2017 value amounting to -0.58%.

  • Tvardi Therapeutics' Return on Assets fell 6.00% to -0.58% in Q3 2017 from the same period last year, while for Sep 2017 it was -0.58%, marking a year-over-year decrease of 6.00%. This contributed to the annual value of -0.66% for FY2016, which is 36.00% down from last year.
  • Tvardi Therapeutics' Return on Assets amounted to -0.58% in Q3 2017, which was up 27.66% from -0.81% recorded in Q2 2017.
  • Over the past 5 years, Tvardi Therapeutics' Return on Assets peaked at -0.11% during Q1 2014, and registered a low of -1.28% during Q1 2017.
  • Its 3-year average for Return on Assets is -0.54%, with a median of -0.43% in 2015.
  • In the last 5 years, Tvardi Therapeutics' Return on Assets climbed by 8bps in 2015 and then plummeted by 100bps in 2017.
  • Quarterly analysis of 4 years shows Tvardi Therapeutics' Return on Assets stood at -0.30% in 2014, then rose by 8bps to -0.22% in 2015, then slumped by 58bps to -0.80% in 2016, then dropped by 6bps to -0.58% in 2017.
  • Its Return on Assets was -0.58% in Q3 2017, compared to -0.81% in Q2 2017 and -1.28% in Q1 2017.